Accendra Health Operating Expenses Growth & History (ACH)
Accendra Health's operating expenses was $2.73B for fiscal 2025.
View full Accendra Health company overviewAccendra Health annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.73B | −$163.3M | −5.63% |
| 2024 | 2024-12-31 | $2.90B | $478.5M | +19.78% |
| 2023 | 2023-12-31 | $2.42B | $735.9M | +43.71% |
| 2022 | 2022-12-31 | $1.68B | $538.7M | +47.06% |
| 2021 | 2021-12-31 | $1.14B | $68.0M | +6.32% |
| 2020 | 2020-12-31 | $1.08B | $21.4M | +2.03% |
| 2019 | 2019-12-31 | $1.06B | −$367.5M | −25.83% |
| 2018 | 2018-12-31 | $1.42B | $340.3M | +31.43% |
| 2017 | 2017-12-31 | $1.08B | $94.9M | +9.61% |
| 2016 | 2016-12-31 | $987.7M | −$26.5M | −2.61% |
| 2015 | 2015-12-31 | $1.01B | $3.8M | +0.37% |
| 2014 | 2014-12-31 | $1.01B | $91.4M | +9.95% |
| 2013 | 2013-12-31 | $919.0M | $191.1M | +26.25% |
| 2012 | 2012-12-31 | $727.9M | $73.9M | +11.30% |
| 2011 | 2011-12-31 | $654.0M | $42.2M | +6.90% |
| 2010 | 2010-12-31 | $611.8M | −$1.3M | −0.22% |
| 2009 | 2009-12-31 | $613.1M | $52.7M | +9.41% |
| 2008 | 2008-12-31 | $560.4M | — | — |
Accendra Health quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $648.4M | −$73.2M | −10.15% |
| Q1 2026 | 2026-03-31 | $610.7M | −$43.4M | −6.64% |
| Q4 2025 | 2025-12-31 | $688.1M | −$384.7M | −35.86% |
| Q3 2025 | 2025-09-30 | $670.8M | $15.0M | +2.29% |
| Q2 2025 | 2025-06-30 | $721.6M | $78.1M | +12.14% |
| Q1 2025 | 2025-03-31 | $654.1M | $128.3M | +24.39% |
| Q4 2024 | 2024-12-31 | $1.07B | $164.2M | +18.07% |
| Q3 2024 | 2024-09-30 | $655.8M | $141.1M | +27.42% |
| Q2 2024 | 2024-06-30 | $643.5M | $134.9M | +26.52% |
| Q1 2024 | 2024-03-31 | $525.8M | $38.3M | +7.86% |
| Q4 2023 | 2023-12-31 | $908.6M | $448.0M | +97.26% |
| Q3 2023 | 2023-09-30 | $514.7M | $61.6M | +13.60% |
| Q2 2023 | 2023-06-30 | $508.6M | $51.2M | +11.19% |
| Q1 2023 | 2023-03-31 | $487.5M | $175.1M | +56.06% |
| Q4 2022 | 2022-12-31 | $460.6M | $181.0M | +64.76% |
| Q3 2022 | 2022-09-30 | $453.0M | $187.1M | +70.34% |
| Q2 2022 | 2022-06-30 | $457.4M | $154.2M | +50.87% |
| Q1 2022 | 2022-03-31 | $312.4M | $16.3M | +5.52% |
| Q4 2021 | 2021-12-31 | $279.5M | −$23.4M | −7.71% |
| Q3 2021 | 2021-09-30 | $266.0M | −$2.8M | −1.05% |
| Q2 2021 | 2021-06-30 | $303.2M | $56.0M | +22.64% |
| Q1 2021 | 2021-03-31 | $296.1M | $38.3M | +14.84% |
| Q4 2020 | 2020-12-31 | $302.9M | $32.7M | +12.11% |
| Q3 2020 | 2020-09-30 | $268.8M | $14.3M | +5.61% |
| Q2 2020 | 2020-06-30 | $247.2M | −$23.4M | −8.65% |
| Q1 2020 | 2020-03-31 | $257.8M | −$2.2M | −0.85% |
| Q4 2019 | 2019-12-31 | $270.2M | −$23.9M | −8.14% |
| Q3 2019 | 2019-09-30 | $254.5M | −$76.7M | −23.16% |
| Q2 2019 | 2019-06-30 | $270.6M | −$226.4M | −45.55% |
| Q1 2019 | 2019-03-31 | $260.0M | −$40.5M | −13.46% |
| Q4 2018 | 2018-12-31 | $294.1M | −$29.8M | −9.21% |
| Q3 2018 | 2018-09-30 | $331.2M | $58.9M | +21.65% |
| Q2 2018 | 2018-06-30 | $497.0M | $256.3M | +106.50% |
| Q1 2018 | 2018-03-31 | $300.5M | $54.8M | +22.31% |
| Q4 2017 | 2017-12-31 | $324.0M | $78.0M | +31.72% |
| Q3 2017 | 2017-09-30 | $272.3M | $29.6M | +12.18% |
| Q2 2017 | 2017-06-30 | $240.7M | −$6.7M | −2.70% |
| Q1 2017 | 2017-03-31 | $245.7M | −$6.0M | −2.39% |
| Q4 2016 | 2016-12-31 | $246.0M | −$8.4M | −3.29% |
| Q3 2016 | 2016-09-30 | $242.7M | −$10.1M | −3.99% |
| Q2 2016 | 2016-06-30 | $247.4M | −$3.1M | −1.24% |
| Q1 2016 | 2016-03-31 | $251.7M | −$5.0M | −1.93% |
| Q4 2015 | 2015-12-31 | $254.3M | −$18.9M | −6.92% |
| Q3 2015 | 2015-09-30 | $252.8M | −$4.3M | −1.68% |
| Q2 2015 | 2015-06-30 | $250.5M | $5.3M | +2.16% |
| Q1 2015 | 2015-03-31 | $256.6M | $21.7M | +9.24% |
| Q4 2014 | 2014-12-31 | $273.2M | $32.9M | +13.69% |
| Q3 2014 | 2014-09-30 | $257.1M | $33.0M | +14.72% |
| Q2 2014 | 2014-06-30 | $245.2M | $21.8M | +9.75% |
| Q1 2014 | 2014-03-31 | $234.9M | $3.7M | +1.62% |
| Q4 2013 | 2013-12-31 | $240.3M | $14.6M | +6.47% |
| Q3 2013 | 2013-09-30 | $224.1M | $42.7M | +23.51% |
| Q2 2013 | 2013-06-30 | $223.4M | $65.1M | +41.16% |
| Q1 2013 | 2013-03-31 | $231.2M | $68.7M | +42.30% |
| Q4 2012 | 2012-12-31 | $225.7M | $54.7M | +32.01% |
| Q3 2012 | 2012-09-30 | $181.5M | $23.2M | +14.69% |
| Q2 2012 | 2012-06-30 | $158.3M | −$6.8M | −4.11% |
| Q1 2012 | 2012-03-31 | $162.5M | $2.7M | +1.68% |
| Q4 2011 | 2011-12-31 | $171.0M | $2.5M | +1.47% |
| Q3 2011 | 2011-09-30 | $158.2M | $9.6M | +6.44% |
| Q2 2011 | 2011-06-30 | $165.0M | $18.2M | +12.43% |
| Q1 2011 | 2011-03-31 | $159.8M | $11.9M | +8.07% |
| Q4 2010 | 2010-12-31 | $168.5M | — | — |
| Q3 2010 | 2010-09-30 | $148.6M | $991,000 | +0.67% |
| Q2 2010 | 2010-06-30 | $146.8M | −$2.0M | −1.33% |
| Q1 2010 | 2010-03-31 | $147.8M | — | — |
| Q3 2009 | 2009-09-30 | $147.7M | — | — |
| Q2 2009 | 2009-06-30 | $148.8M | — | — |
Accendra Health operating expenses trends
Over the last five fiscal years, Accendra Health's operating expenses increased from $1.08B to $2.73B, a change of $1.66B. The latest reported quarter, Q2 2026, shows $648.4M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accendra Health source filings ↗